| 原发灶 | |
|---|---|
| Tx | 原发肿瘤无法评估 |
| T0 | 无原发肿瘤的证据 |
| Tis | 原位癌 |
| T1 | 深度小于或等于1.0mm |
| T1a | 无溃疡且核分裂＜1/mm2 |
| T1b | 有溃疡或核分裂≥1/mm2 |
| T2 | 深度1.01-2.0mm |
| T2a | 无溃疡 |
| T2b | 有溃疡 |
| T3 | 深度2.01-4.0mm |
| T3a | 无溃疡 |
| T3b | 有溃疡 |
| T4 | 深度大于4.0mm |
| T4a | 无溃疡 |
| T4b | 有溃疡 |
| 区域淋巴结 | |
|---|---|
| Nx | 区域淋巴结无法评估 |
| N0 | 无区域淋巴结转移 |
| N1 | 1个淋巴结转移 |
| N1a | 微转移（镜下可见） |
| N1b | 明显转移（临床可见） |
| N2 | 2-3个淋巴结转移 |
| N2a | 微转移（镜下可见） |
| N2b | 明显转移（临床可见） |
| N2c | 途径转移（In transit met），或卫星病灶不伴淋巴结转移 |
| N3 | ≥4个淋巴结转移，或融合的淋巴结转移，或淋巴结转移伴途径转移或卫星病灶 |
| 远处转移 | |
|---|---|
| M0 | 无远处转移 |
| M1a | 转移至皮肤、皮下组织或远处淋巴结 |
| M1b | 转移至肺 |
| M1c | 转移至其它内脏，或任何部位的远处转移伴血清LDH升高 |
| 解剖分期/预后分组 | |||||||
|---|---|---|---|---|---|---|---|
| 临床分期 | 病理分期 | ||||||
| Stage | T | N | M | Stage | T | N | M |
| 0 | Tis | N0 | M0 | 0 | Tis | N0 | M0 |
| ⅠA | T1a | N0 | M0 | ⅠA | T1a | N0 | M0 |
| ⅠB | T1b | N0 | M0 | ⅠB | T1b | N0 | M0 |
| T2a | N0 | M0 | T2a | N0 | M0 | ||
| ⅡA | T2b | N0 | M0 | ⅡA | T2b | N0 | M0 |
| T3a | N0 | M0 | T3a | N0 | M0 | ||
| ⅡB | T3b | N0 | M0 | ⅡB | T3b | N0 | M0 |
| T4a | N0 | M0 | T4a | N0 | M0 | ||
| ⅡC | T4b | N0 | M0 | ⅡC | T4b | N0 | M0 |
| Ⅲ | any T | ≥N1 | M0 | ⅢA | T1-T4a | N1a | M0 |
| T1-T4a | N2a | M0 | |||||
| ⅢB | T1-T4b | N1a | M0 | ||||
| T1-T4b | N2a | M0 | |||||
| T1-T4a | N1b | M0 | |||||
| T1-T4a | N2b | M0 | |||||
| T1-T4a | N2c | M0 | |||||
| ⅢC | T1-T4b | N1b | M0 | ||||
| T1-T4b | N2b | M0 | |||||
| T1-T4b | N2c | M0 | |||||
| any T | N3 | M0 | |||||
| Ⅳ | any T | any N | M1 | Ⅳ | any T | any N | M1 |
| 结果解读 | |
|---|---|
| 相关解释 | |
| 参考来源 | 第七版AJCC癌症分期手册 A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook（2012）. |